m+Medelevator.RU
← Поиск публикаций
Cureus · 2024

Exploring Surgical Management Strategies for Endobronchial Tumors.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Thi Chau P, Vinh Vu Huu, Nhat Lam X

Аннотация

Endobronchial tumors, though relatively uncommon, present a diverse array of pathological conditions, including both benign and malignant neoplasms. This retrospective study focuses on the surgical management of seven such cases affecting the main or lobar bronchi. The study involves a diverse patient population, ranging in age from 18 to 65 years, with a median age of 26 years. The cases include both male and female individuals, indicating the presence of these tumors across various demographics. We carried out surgical interventions to remove the tumor while preserving the lung parenchyma. Surgical techniques included video-assisted thoracic surgery (VATS), lobectomy, and/or a combination of these methods. The choice of approach was guided by the tumor's location and nature. VATS, although widely performed, can sometimes pose challenges, leading to conversions to open thoracotomy in specific cases. All seven cases resulted in uneventful postoperative periods and excellent long-term outcomes, affirming the efficacy of the surgical procedures. Notably, despite variations in age and gender, the treatment approaches consistently yielded favorable long-term results. This study demonstrates the importance of personalized surgical strategies for endobronchial tumors while considering the nature and location of the tumor. VATS stands as a viable option, particularly in benign cases, provided careful case selection and the availability of skilled surgeons. These findings contribute to the growing body of evidence supporting the benefits of VATS in the management of endobronchial tumors.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты